Hunan Jingfeng Pharmaceutical Financial Flexibility Index
Hunan Jingfeng Pharmaceutical financial flexibility index. Hunan Jingfeng Pharmaceutical (000908) has a Financial Flexibility Index of 0.14x as of September 2025. Free cash flow of CN¥126.51 Million (operating CF CN¥125.78 Million minus capex CN¥729.48K) represents 0% of total liabilities (CN¥915.74 Million). See cash generation quality of Hunan Jingfeng Pharmaceutical to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Hunan Jingfeng Pharmaceutical (1999–2024)
Financial flexibility index of Hunan Jingfeng Pharmaceutical from 1999 to 2024. Historical Financial Flexibility Index trend for Hunan Jingfeng Pharmaceutical across 26 annual periods. Check Hunan Jingfeng Pharmaceutical earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Hunan Jingfeng Pharmaceutical Financial Flexibility Index by Year (1999–2024)
Hunan Jingfeng Pharmaceutical financial flexibility index by year from 1999 to 2024. Year-by-year free cash flow to debt coverage for Hunan Jingfeng Pharmaceutical. For the full cash flow conversion analysis, see Hunan Jingfeng Pharmaceutical operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.00x | CN¥-4.17 Million | CN¥-5.55 Million | CN¥955.11 Million | ▼ -111.7% |
| 2023 | 0.04x | CN¥45.48 Million | CN¥35.06 Million | CN¥1.21 Billion | ▼ -65.7% |
| 2022 | 0.11x | CN¥136.78 Million | CN¥123.27 Million | CN¥1.25 Billion | ▼ -1.3% |
| 2021 | 0.11x | CN¥161.95 Million | CN¥123.83 Million | CN¥1.46 Billion | ▲ +229.2% |
| 2020 | -0.09x | CN¥-175.64 Million | CN¥-271.68 Million | CN¥2.05 Billion | ▼ -237.6% |
| 2019 | 0.06x | CN¥149.81 Million | CN¥36.17 Million | CN¥2.41 Billion | ▼ -71.8% |
| 2018 | 0.22x | CN¥522.05 Million | CN¥350.94 Million | CN¥2.37 Billion | ▲ +10.1% |
| 2017 | 0.20x | CN¥454.88 Million | CN¥151.65 Million | CN¥2.27 Billion | ▲ +90.7% |
| 2016 | 0.11x | CN¥265.13 Million | CN¥12.32 Million | CN¥2.52 Billion | ▼ -60.2% |
| 2015 | 0.26x | CN¥315.58 Million | CN¥92.37 Million | CN¥1.19 Billion | ▼ -20.7% |
| 2014 | 0.33x | CN¥306.53 Million | CN¥205.93 Million | CN¥919.76 Million | ▲ +6485.7% |
| 2013 | -0.01x | CN¥-1.73 Million | CN¥-3.44 Million | CN¥331.47 Million | ▼ -140.6% |
| 2012 | 0.01x | CN¥5.53 Million | CN¥351.50K | CN¥430.29 Million | ▲ +367.5% |
| 2011 | 0.00x | CN¥-2.02 Million | CN¥-6.87 Million | CN¥420.66 Million | ▲ +82.4% |
| 2010 | -0.03x | CN¥-11.28 Million | CN¥-15.21 Million | CN¥413.53 Million | ▼ -15178.7% |
| 2009 | 0.00x | CN¥-122.19K | CN¥-11.88 Million | CN¥684.14 Million | ▼ -100.2% |
| 2008 | 0.09x | CN¥57.92 Million | CN¥31.02 Million | CN¥650.60 Million | ▼ -19.6% |
| 2007 | 0.11x | CN¥52.84 Million | CN¥52.26 Million | CN¥477.43 Million | ▼ -8.1% |
| 2006 | 0.12x | CN¥58.52 Million | CN¥57.90 Million | CN¥486.08 Million | ▲ +205.7% |
| 2005 | -0.11x | CN¥-58.15 Million | CN¥-59.49 Million | CN¥510.48 Million | ▲ +58.5% |
| 2004 | -0.27x | CN¥-150.89 Million | CN¥-156.37 Million | CN¥550.11 Million | ▼ -510.5% |
| 2003 | 0.07x | CN¥37.66 Million | CN¥22.51 Million | CN¥563.64 Million | ▼ -80.4% |
| 2002 | 0.34x | CN¥117.41 Million | CN¥17.59 Million | CN¥343.98 Million | ▼ -41.9% |
| 2001 | 0.59x | CN¥72.00 Million | CN¥30.50 Million | CN¥122.47 Million | ▲ +464.5% |
| 2000 | 0.10x | CN¥20.55 Million | CN¥-25.05 Million | CN¥197.38 Million | ▼ -32.6% |
| 1999 | 0.15x | CN¥31.92 Million | CN¥13.64 Million | CN¥206.51 Million | — |